Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol DVA
- Company DaVita Inc.
- Price $132.88
- Changes Percentage 19.51
- Change 21.69
- Day Low $125
- Day High $139.86
- Year High $178.47
- Year Low $101
- Market Cap $9,381,328,000
- Price Avg 50 EMA (D) $113.73
- Price Avg 200 EMA (D) $129.88
- Exchange NYSE
- Volume 2,900,612
- Average Volume 931,342
- Open $128
- Previous Close $111.19
- EPS 9.51
- PE 13.97
- Earnings Announcement 2026-04-30 12:00:00
- Shares Outstanding $70,600,000
Company brief: DAVITA INC. (DVA )
- Healthcare
- Medical - Care Facilities
- Mr. Javier J. Rodriguez
- https://www.davita.com
- US
- N/A
- 10-31-1995
- US23918K1088
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
DVA Corporation News
DaVita Stock Up Following Q4 Earnings & Revenue Beat, Margins Expand
zacks.com -- DVA reports a fourth-quarter 2025 earnings and revenue beat as margins expanded and full-year adjusted EPS rose by double digits....
DaVita Inc. (DVA) Q4 2025 Earnings Call Transcript
seekingalpha.com -- DaVita Inc. (DVA) Q4 2025 Earnings Call Transcript...
